Cogent Biosciences (COGT)
NASDAQ:COGT
US Market
Holding COGT?
Track your performance easily

Cogent Biosciences (COGT) Financial Statements

537 Followers

Cogent Biosciences Financial Overview

Cogent Biosciences's market cap is currently ―. The company's EPS TTM is $-2.479; its P/E ratio is -4.12; Cogent Biosciences is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $-0.57. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue--$ 950.00K--
Gross Profit--$ 950.00K--
EBIT$ -58.95M$ -62.40M$ -58.23M$ -59.58M$ -44.08M
EBITDA$ -56.47M$ -61.34M$ -57.43M$ -58.73M$ -41.82M
Net Income Common Stockholders$ -58.95M$ -58.35M$ -54.37M$ -55.38M$ -44.08M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 363.22M$ 435.74M$ 265.71M$ 279.04M$ 329.40M
Total Assets$ 429.94M$ 476.11M$ 313.44M$ 355.45M$ 392.37M
Total Debt$ 18.18M$ 18.52M$ 18.85M$ 19.17M$ 19.36M
Net Debt$ -345.03M$ -417.22M$ -246.86M$ -259.87M$ -310.04M
Total Liabilities$ 56.71M$ 53.78M$ 55.63M$ 52.55M$ 43.94M
Stockholders Equity$ 319.14M$ 260.22M$ 257.80M$ 302.90M$ 348.43M
Cash Flow-
Free Cash Flow$ -42.85M$ -52.60M$ -44.38M$ -38.09M$ -33.32M
Operating Cash Flow$ -42.70M$ -52.53M$ -44.07M$ -37.97M$ -32.07M
Investing Cash Flow$ -84.63M$ 1.04M$ 10.49M$ -90.54M$ -77.66M
Financing Cash Flow$ -256.00K$ 214.06M-$ 1.00M$ 162.09M
Currency in USD

Cogent Biosciences Earnings and Revenue History

Cogent Biosciences Debt to Assets

Cogent Biosciences Cash Flow

Cogent Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis